Skip to main content

ADVERTISEMENT

comparative effectiveness

Research in Review
10/12/2016
JCP Editors
Clinical pathways developed in accordance with national guidelines can improve adherence to recommendations regarding the use of empiric vancomycin in patients with febrile neutropenia (FN), according to a study...
Clinical pathways developed in accordance with national guidelines can improve adherence to recommendations regarding the use of empiric vancomycin in patients with febrile neutropenia (FN), according to a study...
...
10/12/2016
Journal of Clinical Pathways
Research in Review
10/12/2016
JCP Editors
Studies have assessed the feasibility of fast-track surgery in patients undergoing bariatric surgery. However, findings from a recent study published in Obesity Surgery showed that the degree of obesity influences...
Studies have assessed the feasibility of fast-track surgery in patients undergoing bariatric surgery. However, findings from a recent study published in Obesity Surgery showed that the degree of obesity influences...
...
10/12/2016
Journal of Clinical Pathways
Research in Review
10/12/2016
JCP Editors
The soaring in prices of disease-modifying therapies (DMTs) for multiple sclerosis (MS) over the last several years has resulted in significant increases in the costs of MS-related care. In a new study, published in...
The soaring in prices of disease-modifying therapies (DMTs) for multiple sclerosis (MS) over the last several years has resulted in significant increases in the costs of MS-related care. In a new study, published in...
The...
10/12/2016
Journal of Clinical Pathways
Research in Review
10/11/2016
JCP Editors
Adjuvant endocrine therapy with tamoxifen or aromatase inhibitors may reduce the risk for contralateral breast cancer (CBC) in women with invasive breast cancer according to results from a study published in JAMA...
Adjuvant endocrine therapy with tamoxifen or aromatase inhibitors may reduce the risk for contralateral breast cancer (CBC) in women with invasive breast cancer according to results from a study published in JAMA...
...
10/11/2016
Journal of Clinical Pathways
Research in Review
10/07/2016
JCP Editors
Results from a phase I/II single-arm trial suggest that blinatumomab may have an antileukemic effect in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). ALL is a progressive...
Results from a phase I/II single-arm trial suggest that blinatumomab may have an antileukemic effect in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). ALL is a progressive...
...
10/07/2016
Journal of Clinical Pathways
Research in Review
10/07/2016
JCP Editors
Patients with stage IIIA non-small cell lung cancer (NSCLC) who undergo surgery later than 6 weeks after neoadjuvant chemoradiation (NCRT) may experience significantly lower overall survival, according to results...
Patients with stage IIIA non-small cell lung cancer (NSCLC) who undergo surgery later than 6 weeks after neoadjuvant chemoradiation (NCRT) may experience significantly lower overall survival, according to results...
...
10/07/2016
Journal of Clinical Pathways
Quiz
10/06/2016
JCP Editors
In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, researchers found that which form of radiation therapy offers similar health-related quality of life outcomes in...
In the first study to evaluate patient-reported outcomes from the NRG Oncology/RTOG 0415 trial, researchers found that which form of radiation therapy offers similar health-related quality of life outcomes in...
In the...
10/06/2016
Journal of Clinical Pathways
Department
10/03/2016
JCP Editors
Patients treated with intensity-modulated radiation therapy (IMRT) for cervical or endometrial cancer have fewer adverse events and experience better quality of life than those treated with conventional radiation...
Patients treated with intensity-modulated radiation therapy (IMRT) for cervical or endometrial cancer have fewer adverse events and experience better quality of life than those treated with conventional radiation...
...
10/03/2016
Journal of Clinical Pathways
Quiz
09/29/2016
JCP Editors
Bevacizumab, added to standard adjuvant therapy with capecitabine, offered no benefit to patients with which of the following cancer types? colorectal cancer small cell lung cancer non-small cell lung...
Bevacizumab, added to standard adjuvant therapy with capecitabine, offered no benefit to patients with which of the following cancer types? colorectal cancer small cell lung cancer non-small cell lung...
...
09/29/2016
Journal of Clinical Pathways
Department
09/29/2016
JCP Editors
High-dose stereotactic body radiotherapy (SBRT) for men with newly-diagnosed low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates,...
High-dose stereotactic body radiotherapy (SBRT) for men with newly-diagnosed low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates,...
...
09/29/2016
Journal of Clinical Pathways